Dabur Pharma gets nod for Irinotecan in Italy, Denmark
New Delhi, Mar 11 (UNI) Dabur Pharma Ltd today said it has received the approval to launch its Irinotecan Hydrochloride injection in Italy and Denmark.
Irinotecan is used for patients with carcinoma of the colon or rectum, it said in a statement.
The company had recently launched the generic version of the drug in the US and the UK.
UNI SR PDT BD2040
More From
-
Gold Silver Rate Today, 11 March 2026: City-Wise Prices, MCX Gold Gains As Silver Climbs Across India -
Trump Says Iran War Could End ‘Any Time I Want’, Claims Tehran’s Military ‘Practically Destroyed’ -
Kerala Gold Rate Today: 24K Gold Drops Slightly, Silver Also Declines -
Men Are The Biggest Victims: Jayam Ravi Amid Vijay-Sangeetha Divorce Row Linked To Trisha -
UPSC Result: Astha Jain’s Rank 9 Achievement Sparks EWS Quota Debate -
India Comes To Bangladesh’s Rescue Amid Diesel Shortage Triggered By Iran War, Sends 5,000 Tonnes Of Diesel -
Bangalore Gold Silver Rate Today, March 11, 2026: Gold Prices Jump, Silver Steady as Global Tensions Push Safe -
The Reality Behind India’s LPG Crisis Debate: Global Energy Shock, Not Policy Failure -
Hyderabad Gold Silver Rate Today, 11 March 2026: Gold, Silver Prices Decline Again; Buyers Get Relief -
Legends League Cricket 2026: Mumbai Spartans Face India Capitals in Opening Clash -
No Petrol, Diesel Or LPG Shortage In UP, Says CM Yogi Adityanath; Warns Of Gangster Act Against Hoarders -
Commercial LPG Crisis In Hyderabad: 90 Percent Of Hotels, Restaurants Likely To Shut Within 48 Hours
Click it and Unblock the Notifications
Sign in with Google